𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

✍ Scribed by Rudolph M. Navari; Lawrence H. Einhorn; Patrick J. Loehrer; Steven D. Passik; Jake Vinson; John McClean; Naveed Chowhan; Nasser H. Hanna; Cynthia S. Johnson


Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
165 KB
Volume
15
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Randomized, placebo-controlled, pilot st
✍ Jon D. Herrington; Adam D. Jaskiewicz; Juhee Song πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract ## BACKGROUND. The combination of palonosetron and aprepitant is safe and effective in the prevention of chemotherapy‐induced emesis (CIE). The purpose of this pilot study was to ascertain the effectiveness of 1‐day versus 3‐day aprepitant in the prevention of acute and delayed nausea